litlas
ログインアカウント作成

Matthew W. Johnson

2002–2025 年に発表

別表記
Matthew W Johnson
114
論文数
23,070
被引用数
72
h 指数
100
i10 指数

被引用数

Matthew W. Johnson の年別被引用数1986 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 6 件2004 年: 被引用 12 件2005 年: 被引用 18 件2006 年: 被引用 26 件2007 年: 被引用 24 件2008 年: 被引用 40 件2009 年: 被引用 50 件2010 年: 被引用 36 件2011 年: 被引用 72 件2012 年: 被引用 74 件2013 年: 被引用 78 件2014 年: 被引用 123 件2015 年: 被引用 146 件2016 年: 被引用 211 件2017 年: 被引用 248 件2018 年: 被引用 314 件2019 年: 被引用 526 件2020 年: 被引用 866 件2021 年: 被引用 1,014 件2022 年: 被引用 1,265 件2023 年: 被引用 847 件2024 年: 被引用 1,305 件2025 年: 被引用 572 件2026 年: 被引用 31 件1987〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,726 件、この内訳の 37.6%イギリス: 引用元論文 513 件、この内訳の 11.2%カナダ: 引用元論文 288 件、この内訳の 6.3%ドイツ: 引用元論文 195 件、この内訳の 4.3%オーストラリア: 引用元論文 192 件、この内訳の 4.2%スイス: 引用元論文 169 件、この内訳の 3.7%オランダ: 引用元論文 160 件、この内訳の 3.5%スペイン: 引用元論文 120 件、この内訳の 2.6%イタリア: 引用元論文 112 件、この内訳の 2.4%中国: 引用元論文 105 件、この内訳の 2.3%ブラジル: 引用元論文 98 件、この内訳の 2.1%フランス: 引用元論文 92 件、この内訳の 2%
0%37.6%その他 17.8%

機関

分野

  • Psychology59.9%
  • Medicine12.7%
  • Neuroscience9.5%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Computer Science4.2%
  • Decision Sciences3.8%
  • その他4.8%

トピック

  • Psychedelics and Drug Studies18.5%
  • Neurotransmitter Receptor Influence on Behavior9.8%
  • Chemical synthesis and alkaloids7.1%
  • Forensic Toxicology and Drug Analysis5.7%
  • Pain Management and Placebo Effect2.9%
  • Biochemical Analysis and Sensing Techniques2.5%
  • その他53.5%

共著者

全論文

検索で開く
  1. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

    著者: Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P Cosimano, Margaret A. Klinedinst - Journal of Psychopharmacology 2016 被引用: 2,163

  2. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    著者: Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, Roland R. Griffiths - JAMA Psychiatry 2020 被引用: 1,258

  3. Single-Dose Psilocybin Treatment for Major Depressive Disorder

    著者: Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths - JAMA 2023 被引用: 484

  4. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

    著者: Natalie Gukasyan, Alan K. Davis, Frederick S. Barrett, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Roland R. Griffiths - Journal of Psychopharmacology 2022 被引用: 413

  5. Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction

    著者: Matthew W. Johnson, Albert Garcia‐Romeu, Mary P Cosimano, Roland R. Griffiths - Journal of Psychopharmacology 2014 被引用: 904

  6. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

    著者: Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths - Journal of Psychopharmacology 2015 被引用: 630

  7. Long-term follow-up of psilocybin-facilitated smoking cessation

    著者: Matthew W. Johnson, Albert Garcia‐Romeu, Roland R. Griffiths - The American Journal of Drug and Alcohol Abuse 2016 被引用: 698

  8. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

    著者: Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐Marie Leoutsakos, Matthew W. Johnson, Roland R. Griffiths - Journal of Psychopharmacology 2016 被引用: 362

  9. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

    著者: Roland R. Griffiths, Matthew W. Johnson, William A. Richards, Brian D. Richards, Una D. McCann, Robert L. Jesse - Psychopharmacology 2011 被引用: 937

  10. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

    著者: Theresa M. Carbonaro, Matthew P. Bradstreet, Frederick S. Barrett, Katherine A. MacLean, Robert L. Jesse, Matthew W. Johnson, Roland R. Griffiths - Journal of Psychopharmacology 2016 被引用: 539

  11. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

    著者: Nurulamin M Noor, James Lee, Simon Bond, Francis Dowling, Biljana Brezina, Kamal Patel, Tariq Ahmad, Paul Banim, James Berrill, Rachel Cooney, Juan De La Revilla Negro, Shanika de Silva, Shahida Din, Dharmaraj Durai, J Gordon, Peter M. Irving, Matthew W. Johnson, Alexandra Kent, Klaartje Kok, Gordon W. Moran, Craig Mowat, Pritash Patel, C Probert, Tim Raine, Rebecca Saich, Abigail Seward, Dan Sharpstone, Melissa Smith, Sreedhar Subramanian, Sara Upponi, Alan A. Wiles, Horace R. Williams, Gijs R. van den Brink, Séverine Vermeire, Vipul Jairath, Geert D’Haens, Eoin McKinney, Paul Lyons, James O. Lindsay, Nicholas A. Kennedy, Kenneth G. C. Smith, Miles Parkes, Nurulamin M Noor, James Lee, Simon Bond, Francis Dowling, Biljana Brezina, Kamal Patel, Tariq Ahmad, Paul Banim, James Berrill, Rachel Cooney, Juan De La Revilla Negro, Shanika de Silva, Shahida Din, Dharmaraj Durai, J Gordon, Peter M. Irving, Matthew W. Johnson, Alexandra Kent, Klaartje Kok, Gordon W. Moran, Craig Mowat, Pritash Patel, C Probert, Tim Raine, Rebecca Saich, Abigail Seward, Dan Sharpstone, Melissa Smith, Sreedhar Subramanian, Sara Upponi, Alan A. Wiles, Horace R. Williams, Gijs van Den Brink, Séverine Vermeire, Vipul Jairath, Geert D’Haens, Eoin McKinney, Paul Lyons, James O. Lindsay, Nicholas A. Kennedy, Kenneth G. C. Smith, Miles Parkes, Clare Allcock, Suhaylah Bhatti, Jonathan Blackwell, Robert Boulton-Jones, Matthew Brookes, Rhys O. Butcher, Jeffrey Butterworth, Karlena Champion, Rakesh Chaudhary, Andy Cole, Lauranne Derikx, Anjan Dhar, Mary Flowerdew, Rishi Goel, Ailsa Hart, R Hughes ほか 17 名 - ˜The œLancet. Gastroenterology & hepatology 2024 被引用: 281

  12. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    著者: Katherine A. MacLean, Matthew W. Johnson, Roland R. Griffiths - Journal of Psychopharmacology 2011 被引用: 905

  13. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

    著者: Matthew W. Johnson, Peter S. Hendricks, Frederick S. Barrett, Roland R. Griffiths - Pharmacology & Therapeutics 2018 被引用: 519

  14. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

    著者: Roland R. Griffiths, Matthew W. Johnson, William A. Richards, Brian D. Richards, Robert L. Jesse, Katherine A. MacLean, Frederick S. Barrett, Mary P Cosimano, Maggie A Klinedinst - Journal of Psychopharmacology 2017 被引用: 526

  15. Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

    著者: Albert Garcia‐Romeu, Roland R. Griffiths, Matthew W. Johnson - Current Drug Abuse Reviews 2015 被引用: 480

  16. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin

    著者: Katherine A. MacLean, Jeannie‐Marie Leoutsakos, Matthew W. Johnson, Roland R. Griffiths - Journal for the Scientific Study of Religion 2012 被引用: 412

  17. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

    著者: Matthew W. Johnson, Roland R. Griffiths, Peter S. Hendricks, Jack E. Henningfield - Neuropharmacology 2018 被引用: 344

  18. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts

    著者: Tehseen Noorani, Albert Garcia‐Romeu, Thomas Cody Swift, Roland R. Griffiths, Matthew W. Johnson - Journal of Psychopharmacology 2018 被引用: 283

  19. Cessation and reduction in alcohol consumption and misuse after psychedelic use

    著者: Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, Earth Erowid, Roland R. Griffiths, Matthew W. Johnson - Journal of Psychopharmacology 2019 被引用: 284

  20. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey

    著者: Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe, Hadi Zaki, Trey Brasher, Matthew X. Lowe, Del R. P. Jolly, Frederick S. Barrett, Roland R. Griffiths, Justin C. Strickland, Matthew W. Johnson, Heather Jackson, Albert Garcia‐Romeu - Frontiers in Psychiatry 2023 被引用: 85

  21. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

    著者: Peter S. Hendricks, Christopher B. Thorne, C. Brendan Clark, David Coombs, Matthew W. Johnson - Journal of Psychopharmacology 2015 被引用: 376

  22. Potential Therapeutic Effects of Psilocybin

    著者: Matthew W. Johnson, Roland R. Griffiths - Neurotherapeutics 2017 被引用: 301

  23. Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches

    著者: Albert Garcia‐Romeu, Frederick S. Barrett, Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths - Journal of Psychopharmacology 2021 被引用: 99

  24. Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

    著者: Christina Kapizioni, R Desoki, Danielle Lam, Karthiha Balendran, Eman AlSulais, Sreedhar Subramanian, Joanna Rimmer, Juan De La Revilla Negro, Holly Pavey, Laetitia Pele, Johanne Brooks, Gordon W. Moran, Peter M. Irving, Jimmy K. Limdi, Christopher A Lamb, UK IBD BioResource Investigators, Christopher Alexakis, Mohammed Allah-Ditta, Richard Appleby, Bijay Baburajan, Michelle Baker-Moffatt, Tyara Banerjee, Paul Banim, John Beckly, Roisin Bevan, Stuart Bloom, Monica Bose, Elaine Brinkworth, Johanne Brooks, Deborah Butcher, Jeffrey Butterworth, Mónica Chan, Katie Clark, A.T. Cole, Joseph Collum, Rachel Cooney, Fraser Cummings, Albert Davies, Aminda De Silva, John de Caestecker, Anjan Dhar, Stacey Duffy, Dharmaraj Durai, Cathryn Edwards, Stephen Foley, Tessa Glazebrook, John Gordon, Michael Grimes, Anton Gunasekera, Laura Hancock, Mina Hanna, Ailsa Hart, Gini Hay, David Hobday, Patricia Hooper, Mark Jarvis, Babur Javaid, Matthew W. Johnson, Lijo Joy, Rzwan Kassam, Nick Kennedy, Alexandra Kent, Klaartje Kok, Konrad Koss, Nicola Lancaster, Jonathan Landy, Charlie W. Lees, Wendy Lewis, Stephen J. Lewis, Andrew A. Li, Alan Lobo, J Loehry, Chris Ewen MacDonald, Christopher Macdonald, George MacFaul, Zahid Mahmood, Dina Mansour, Simon D. McLaughlin, John McLaughlin, Yin Miao, Ajay Muddu, Charles Murray, Chuka Nwokolo, Susan O’Sullivan, A.J. Oglesby, Simon Panter, Vinod Patel, Linda Patterson, Ruth Penn, Anne Phillips, Kath Phillis, Richard Pollok, Sam Powles, Cathryn Preston, Monira Rahman, Arvind Ramadas, John Ramage, S. Ramakrishnan, Jack Satsangi, John B. Saunders ほか 34 名 - Journal of Crohn s and Colitis 2023 被引用: 110